Randomized Trial of Telemedicine for Diabetes Care (IDEATel)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00271739
Recruitment Status : Completed
First Posted : January 4, 2006
Results First Posted : August 10, 2011
Last Update Posted : November 22, 2012
State University of New York - Upstate Medical University
Information provided by (Responsible Party):
Steven J. Shea, Columbia University

Brief Summary:
The IDEATel study is a multicenter randomized controlled trial to evaluate the efficacy, acceptability, and cost-effectiveness of telemedicine case management to provide diabetes care to elderly Medicare beneficiaries residing in medically underserved areas of New York State.

Condition or disease Intervention/treatment Phase
Diabetes Mellitus Device: Telemedicine Unit (HTU) Other: usual care Not Applicable

Detailed Description:
The project is designed as a randomized controlled trial with approximately 750 subjects receiving a telemedicine intervention and approximately 750 receiving usual care. Eligibility requires having diabetes, being a Medicare beneficiary, and living in a medically underserved area. The project is conducted in New York City, in northern Manhattan (urban component), and in rural upstate New York through a consortion of participating institutions based at the State University of New York (SUNY) Upstate Medical University at Syracuse (rural component). Subjects are randomized to receive telemedicine case management or usual care for diabetes. The intervention utilizes a home telemedicine unit (HTU). The HTU is a specially designed, web-enabled device with a data port connected to a home glucometer and home blood pressure cuff whereby measurements obtained with these devices can be directly uploaded to a computer database. A diabetes nurse case manager interacts regularly with intervention participants through videoconference via the HTU.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 1665 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: Informatics for Diabetes Education and Telemedicine (IDEATel)
Study Start Date : December 2000
Actual Primary Completion Date : May 2007
Actual Study Completion Date : May 2007

Arm Intervention/treatment
Experimental: Telemedicine case management
Telemedicine visits conducted by a registered nurse (RN) with remote monitoring of blood pressure (BP) and blood glucose through the use of a telemedicine home unit (HTU).
Device: Telemedicine Unit (HTU)
This study involves the deployment of a home telemedicine unit (HTU). The HTU provides 3 critical functions for patients: videoconferencing, access to information resources and e-mail through a web-enabled workstation, and medical data acquisition through an electronic device interface. The HTUs also included a glucometer and a blood pressure cuff interfaced directly with the HTU.
Other Name: HTU

Active Comparator: Usual care
usual care by primary care provider
Other: usual care
usual diabetes care, as provided by primary care providers

Primary Outcome Measures :
  1. Hemoglobin A1c Levels [ Time Frame: 5 years ]
  2. Blood Pressure Levels [ Time Frame: 5 years ]
  3. Serum Lipids Levels; Low-density Lipoprotein (LDL)-Cholesterol [ Time Frame: 5 years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   55 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age 55 years or greater
  • Being a current Medicare beneficiary (verified by the Centers for Medicare and Medicaid Services)
  • Having diabetes mellitus as defined by a physician's diagnosis and being on treatment with diet, an oral hypoglycemic agent, or insulin
  • Residence in a federally designated medically underserved area (either of two federal designations, Medically Underserved Area [MUA] or Health Manpower Shortage Area [HPSA]) in New York Sate
  • Fluency in either English or Spanish

Exclusion Criteria:

  • Moderate or severe cognitive, visual, or physical impairment
  • The presence of severe co-morbid disease.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00271739

United States, New York
Columbia University
New York, New York, United States, 10032
SUNY Upstate Medical University
Syracuse, New York, United States, 13210
Sponsors and Collaborators
Columbia University
State University of New York - Upstate Medical University
Principal Investigator: Steven Shea, MD Columbia University

Additional Information:
Publications of Results:
Other Publications:
Publications automatically indexed to this study by Identifier (NCT Number):

Responsible Party: Steven J. Shea, Hamilton Southworth Professor of Medicine and Professor of Epidemiology (in Biomedical Informatics); Senior Vice Dean , College of Physicians and Surgeons, Columbia University Identifier: NCT00271739     History of Changes
Other Study ID Numbers: AAAA5372
CMS 95-C-90998 ( Other Identifier: protocol )
First Posted: January 4, 2006    Key Record Dates
Results First Posted: August 10, 2011
Last Update Posted: November 22, 2012
Last Verified: November 2012

Keywords provided by Steven J. Shea, Columbia University:
Diabetes Mellitus

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases